BRD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.767500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.082020E-01
Normal-vs-Stage2
1.252450E-01
Normal-vs-Stage3
1.287020E-01
Normal-vs-Stage4
4.014600E-01
Stage1-vs-Stage2
5.196000E-01
Stage1-vs-Stage3
3.110200E-01
Stage1-vs-Stage4
1.986210E-01
Stage2-vs-Stage3
8.676400E-02
Stage2-vs-Stage4
6.389000E-01
Stage3-vs-Stage4
1.364600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.902100E-02
Normal-vs-AfricanAmerican
4.136600E-01
Normal-vs-Asian
2.449800E-01
Caucasian-vs-AfricanAmerican
6.441600E-01
Caucasian-vs-Asian
7.160200E-01
AfricanAmerican-vs-Asian
6.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.654970E-01
Normal-vs-Female
4.660000E-02
Male-vs-Female
2.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.327800E-01
Normal-vs-Age(41-60Yrs)
2.418600E-01
Normal-vs-Age(61-80Yrs)
6.972300E-02
Normal-vs-Age(81-100Yrs)
5.866100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.948200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.532200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.837240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.763400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.498200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.606400E-01
Normal-vs-Daily Drinker
9.094100E-02
Normal-vs-Weekly Drinker
4.680800E-01
Normal-vs-Occasional Drinker
6.446300E-02
Normal-vs-Social Drinker
1.800620E-01
Non Drinker-vs-Daily Drinker
5.984400E-01
Non Drinker-vs-Weekly Drinker
1.904640E-01
Non Drinker-vs-Occasional Drinker
8.798200E-01
Non Drinker-vs-Social Drinker
2.591800E-01
Daily Drinker-vs-Weekly Drinker
8.148300E-02
Daily Drinker-vs-Occasional Drinker
4.814200E-01
Daily Drinker-vs-Social Drinker
1.292410E-01
Weekly Drinker-vs-Occasional Drinker
1.669230E-01
Weekly Drinker-vs-Social Drinker
6.072800E-01
Occasional Drinker-vs-Social Drinker
2.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.242000E-01
Normal-vs-Grade 2
7.278400E-01
Normal-vs-Grade 3
7.018200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.488000E-01
Grade 1-vs-Grade 3
1.175970E-01
Grade 1-vs-Grade 4
5.242000E-01
Grade 2-vs-Grade 3
5.234200E-01
Grade 2-vs-Grade 4
7.278400E-01
Grade 3-vs-Grade 4
7.018200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.034800E-01
Normal-vs-NonDiabetic
9.074400E-02
Diabetic-vs-NonDiabetic
8.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.244600E-01
Normal-vs-NoPancreatitis
1.101980E-01
Pancreatitis-vs-NoPancreatitis
6.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.643600E-02
Normal-vs-N1
1.340830E-01
N0-vs-N1
2.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.711700E-02
Normal-vs-TP53-NonMutant
1.322160E-01
TP53-Mutant-vs-TP53-NonMutant
9.874200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
